Skip to main content

Clinical Skills

RheumNow Podcast - Speak Up! (6.18.2021)

Jun 18, 2021

Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!

Read Article

Artificial intelligence brings clarity to early bony changes in inflammatory arthritis

Jun 16, 2021

Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as they progress. As computational techniques have become more sophisticated and more accessible,

Read Article

Current approach to lupus and pregnancy

Jun 14, 2021

All of us are extremely cautious with lupus patients when it comes to pregnancy. Presentation 6888 (Common issues in pregnancy management in lupus and anti-phospholipid syndrome by Dr. Rebecca Fischer-Betz) was an excellent overview of our current approach to lupus and pregnancy. 

Read Article

Q-DAPSA for Measuring Disease Activity in PsA

Jun 10, 2021

Given its multiple domains, there remains much discussion over the best disease activity scoring method in PsA. The proverbial "holy grail" would be a measure that is quick, intuitive, domain comprehensive and validated.

Read Article
I write more about this for @RheumNow - it’s powerful to know that AI can accurately tell the difference between RA, PsA, and healthy controls on the basis of the bony surface at MCP 2: https://t.co/ChDfihnW4f @LkasDer @maier_ak @FAU_Germany OP0145 #EULAR2021 (ping @DrCMcMaster) https://t.co/Pl7yxYfEqr

David Liew @drdavidliew( View Tweet )

Jun 06, 2021
Would you use #Telemedicine (TM) to follow-up #SLE patients post #COVID? Dr So showed in an RCT (N=122),patient satisfaction and time-to-review were better in TM vs Face-to-Face. Although none had COVID, >pts in TM were hospitalised and trend to⬆️FU #EULAR2021 #POS1164 @RheumNow https://t.co/p7aWv4AVm7
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )
Jun 05, 2021
Additional results from @rheum_covid trainee survey re: Telemedicine presented in AB0674: 📱dramatic ⬆️ in telemed (13% to 83%) during pandemic 📱limited training and supervision 📱trainees felt telemed negatively impacted supervision & clin teaching quality #EULAR2021 https://t.co/44X5UprD7V
Kristen Young @kristenyoung( View Tweet )
Jun 03, 2021
Presented results from @rheum_covid Trainee Survey today at #EULAR21 (POS0051): 👎🏼 trainees felt multiple domains in clinical care & research were negatively impacted by pandemic 🔥 50% felt burntout with 68% with ⬆️ of work related stress 🗣@SuAnnYeoh1, @rheumed & team https://t.co/KXei6r6ZHn
Kristen Young @kristenyoung( View Tweet )
Jun 03, 2021
Prof. Alten outlined the value of patient-reported outcomes for clinical practice! How do you collect patient-reported outcomes - PRO - in your rheumatology clinic? #EULAR2021 @RheumNow

Paul Studenic @Stiddyo( View Tweet )

Jun 02, 2021

Foot Pain Commonly Overlooked in RA

MedPage Today
Jun 01, 2021

Foot pain is a common but underappreciated symptom of rheumatoid arthritis (RA) and can be associated with worse disease, European researchers found.



In a cohort of 320 patients with RA, 69% reported foot or ankle pain, according to Morten Bilde Simonsen, PhD, of Aalborg University in

Read Article
DASH study: ?effect of diet on BP in 459 adults given 1) USA diet; 2) Fiber, fruits, Veggie (FFV) or 3) DASH diet. Compared to typical American diet, DASH diet (less so FFV) reduced mean SUA 0.25 mg/dl (P=.004); moreso w/ higher SUA levels https://t.co/XhCK9xp67P

Dr. John Cush @RheumNow( View Tweet )

May 18, 2021

RheumNow Live 2021 Now Available for All

May 14, 2021

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).



RNL has finished its 3rd year as a hybrid meeting, with the live meeting streamed to hundreds at home

Read Article
News Feature: Insurers Bet Big on Bribing Patients https://t.co/Tcip2xODF1 https://t.co/Ieh7yZfurk
Dr. John Cush @RheumNow( View Tweet )
May 12, 2021

ARTIC REWIND - Don't Half DMARD Therapy

May 06, 2021

The ARTIC-REWIND study examined rheumatoid arthritis (RA) patients in remission on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to see if they could "step-down" their csDMARDs theray; but  the study showed that 25% those who went on half-dose experienced disease

Read Article

Drug Monitoring Ineffective with Infliximab Treatment

May 05, 2021

The predictive value of therapeutic drug monitoring (TDM) while on biologics is debateable; gastroenterology routinely relies on TDM, while rheumatologists do not. A randomized trial compared TDM to no TDM in patients receiving infliximab for chronic immune-mediated inflammatory diseases (

Read Article

Seven Year Delay in Diagnosing Spondyloarthritis

Apr 29, 2021

A large patient cohort study suggests that the mean diagnostic delay (DD) in European axial spondyloarthritis (axSpA) patients is 7.4 years, moreso in women and younger patients.



An online survey of 2,652 patients from 13 countries (European Map of Axial Spondyloarthritis - EMAS)

Read Article

Little Effect with Multimodal Treatment of CMC1 Osteoarthritis

Apr 26, 2021

A randomized clinical trial of patients with CMC1 osteoarthritis shows modest benefits when a combination of conservative treatments (education, splinting, hand exercises, 1% diclofenac sodium gel) was used compared to education alone. While there were small to medium benefits with regard to

Read Article

Golimumab Effective in non-radiographic Axial Spondyloarthritis

Apr 26, 2021

The GO-AHEAD study was designed to assess the long-term efficacy and safety of golimumab (GLM) in non-radiographic axial spondyloarthritis (nr-axSpA).  After the 16-week, placebo [PBO]-controlled double-blind phase, 189/198 (95.5%) entered the long-term extension (OLE) for 36 weeks wherein

Read Article

Lupus Activity Affects Mortality

MedPage Today
Apr 23, 2021

Each one-unit increase on a disease activity score during the first year after enrollment into a systemic lupus erythematosus (SLE) cohort was associated with a significant increased risk for death and organ damage during subsequent follow-up, researchers reported.

Read Article

Diagnostic Delay in Spondyloarthritis

Apr 22, 2021

Literature review and metanalysis of many studies suggests that significant delay to diagnosis in axial spondyloarthritis (axSpA) exist, are longer than other rheumatic diseases and have not changed over time.



From a total of 64 studies identified the reported mean delay in diagnosing

Read Article

RheumNow Podcast – Mistakes with Steroids

Apr 08, 2021

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Read Article
New podcast up! Download wherever podcasts are available. Upadacitinib Wins in PsA Dr Jack Cush reviews the news and Journal reports and takes "Back Talk" questions from viewers. https://t.co/ZMAUgn10dU https://t.co/QTDqZW3GgG
Dr. John Cush @RheumNow( View Tweet )
Apr 05, 2021

Enthesitis Responses to Secukinumab in Spondylitis Patients

Mar 16, 2021

Schett and colleagues studies the secukinumab (an IL-17 inhibitor) response in patients from 3 clinical trials with enthesitis and ankylosing spondylitis (AS) and demonstrated consistent efficacy with improved enthesitis scores at both peripheral and axial sites.



Pooled data from the

Read Article

Paucity of Effectiveness Research on Telemedicine in RA

Mar 02, 2021

A systematic review of telehealth in delivering equivalent care in RA patients demonstrates there is limited evidence that virtual RA care is equivalent to conventional face-to-face care. Despite current widespread use, there is a great need for credible well-designed research that will address

Read Article

ANAGO Study - Anakinra for Gout Flare

MedPage Today
Feb 23, 2021

The interleukin (IL)-1 receptor antagonist anakinra (Kineret) was not superior to triamcinolone for relieving gout flares, but had similar effects for pain reduction as the glucocorticoid, a randomized phase II study found.

Read Article
×